Supplementary Figures from Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 1. Immunoblots of Patient Serum before and after Therapy Supplemental Figure 2. Distribution of 1/Nab Titers for the 40 Patients Supplemental Figure 3. Distribution of the Day 2 serum levels of Interferon-alpha Supplemental Figure 4. Lack of Correlation of lymphocyte or macrophage infiltration with survival. Supplemental Figure 5. Lack of Correlation of PDL1 staining with survival. Supplemental Figure 6. Correlation of the mRNA immunoscore with survival.
Authors: Daniel H. Sterman, Evan Alley, James P. Stevenson, Joseph Friedberg, Susan Metzger, Adri Recio, Edmund K. Moon, Andrew R. Haas, Anil Vachani, Sharyn I. Katz, Jing Sun, Daniel F. Heitjan, Wei-Ting Hwang, Leslie Litzky, Jennifer H. Yearley, Kay See Tan, Emmanouil Papasavvas, Paul Kennedy, Luis J. Montaner, Keith A. Cengel, Charles B. Simone, Melissa Culligan, Corey J. Langer, Steven M. Albelda
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361884362